Achieve Life Sciences (ACHV) Reports Q2 Loss of $1.82/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Take-Two stock drops as GTA 6 leaks continue
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- Goldman Sachs raises humanoid robot forecast, sees auto role
- Manhunt underway after woman killed, several injured at Swiss rave shooting
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
August 8, 2018 4:05 PM EDTSEATTLE and VANCOUVER, British Columbia, Aug. 8, 2018 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today provided an update on the cytisine clinical development program and announced second quarter 2018 financial results.
... More